NCT
INICIO RECIENTES ARCHIVO COVID-19
INICIO RECIENTES ARCHIVO PUBLICAR INSTRUCCIONES
PARA AUTORES COVID-19 ENTRAR / REGISTRARSE HISTORIA NOSOTROS DIRECTORIO CONTACTO
El virus del Ébola y la medicina respiratoria

Sergio Monraz-Pérez , Patricia Volkow , Rogelio Pérez-Padilla





2014, Número 3

2014; 73 (3)






RESUMEN

El brote más grande hasta ahora conocido por el virus de Ébola, inició en diciembre 2013, en la nación de Guinea-Conakry al oeste de África, de ahí se diseminó a los vecinos países de Liberia, Sierra Leona y Nigeria.

PALABRAS CLAVE

.

REFERENCIAS

  1. World Health Organization. Global Alert and Response. Ebola virus disease. Accesed on August 22, 2014. Available from: http://www.who.int/csr/disease/ebola/en/.

  2. Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 2014;371(15):1418-1425. doi: 10.1056/NEJMoa1404505.

  3. Koplan J, Del Rio C. Global Health Beyond Ebola. The Atlanta Journal-Constitution. August 2014.

  4. CDC. 2014. Ebola outbreak in West Africa. Atlanta, GA: US Department of Health and Human Services, CDC; 2014. Accesed on September 24, 2014. Available from: http://www.cdc.gov/vhf/ebola/outbreaks/guinea/index.html

  5. CDC. 2014. First imported case of Ebola diagnosed in the United States. Atlanta, GA: US Department of Health and Human Services, CDC; 2014. Accesed on October 1st, 2014. Available from: http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/united-states-imported-case.html

  6. Mahanty S, Bray M. Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis 2004;4(8):487-498.

  7. Centers for Disease Control and Prevention. Case definition for Ebola Virus Disease (EVD). Accessed on August 11, 2014. Available from: http://www.cdc.gov/vhf/ebola/hcp/case-definition.html

  8. Jaax NK, Davis KJ, Geisbert TJ, et al. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med 1996;120(2):140-155.

  9. Schou S, Hansen AK. Marburg and Ebola virus infections in laboratory non-human primates: a literature review. Comp Med 2000;50(2):108-123.

  10. World Health Organization. Barriers to rapid containment of the Ebola outbreak. Accessed on August 12, 2014. Available from: http://www.who.int/csr/disease/ebola/overview-august-2014/en/

  11. Baron RC, McCormick JB, Zubeir OA. Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ 1983;61(6):997-1003.

  12. Georges-Courbot MC, Sanchez A, Lu CY, et al. Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emerg Infect Dis 1997;3(1):59-62.

  13. Nakazibwe C. Marburg fever outbreak leads scientists to suspected disease reservoir. Bull World Health Organ 2007;85(9):654-656.

  14. Piot P, Breman JG, Heymann DL, et al. Clinical aspects of Ebola virus infection in Yambuku area, Zaire, 1976. In: Pattyn S, editor. Ebola virus haemorrhagic fever. Amsterdam: Elsevier/North-Holland; 1978. p.17.

  15. Khan AS, Tshioko FK, Heymann DL, et al. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis 1999;179 Suppl 1:S76-S86.

  16. Mahanty S, Bray M. Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis 2004;4(8):487-498.

  17. Bray M, Geisbert TW. Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 2005; 37(8):1560-1566.

  18. Kobinger GP, Leung A, Neufeld J, et al. Replication, pathogenicity, shedding, and transmission of Zaire ebola virus in pigs. J Infect Dis 2011;204(2):200-208. doi: 10.1093/infdis/jir077.

  19. Bwaka MA, Bonnet MJ, Calain P, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis 1999;179 Suppl 1:S1-S7

  20. Roody P, Howard N, Van Kerkhove MD, et al. ClinicalmManifestations and case managment of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008. PLoS One 2012;7(12): e52986.doi:10.1371/journal.pone.0052986.

  21. Kortepeter MG, Bausch DG, Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis 2011;204 Suppl 3:S810-S816. doi: 10.1093/infdis/jir299.

  22. Sanchez A, Lukwiya M, Bausch D, et al. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) haemorrhagic fever: celular responses, virus load, and nitric oxid levels. J Virol 2004;78(19):10370-10377.

  23. Rowe AK, Bertolli J, Khan AS, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis 1999;179 Suppl 1:S28-S35.

  24. Centers for Disease Control and Prevention. Infection Prevention and Control Recommendations for Hospitalized Patients with Known or Suspected Ebola Virus Disease in U.S. Hospitals. Atlanta, GA: US Department of Health and Human Services, CDC; 2014. Accesed on September 24, 2014. Available from: http://www.cdc.gov/vhf/ebola/hcp/infection-prevention-and-control-recommendations.html

  25. Centers for Disease Control and Prevention. Interim Guidance for Environmental Infection Control in Hospitals for Ebola Virus. Atlanta, GA: US Department of Health and Human Services, CDC; 2014. Accesed on September 24, 2014. Available from: http://www.cdc.gov/vhf/ebola/hcp/environmental-infection-control-in-hospitals.html

  26. Kanapathipillai R, Restrepo AM, Fast P. Ebola vaccine - An Urgent International Priority. N Engl J Med 2014. doi: 10.1056/NEJMp1412166


2014, Número 3

2014; 73 (3)